The hepatic uptake of intravenously injected beta-very low density lip
oprotein (beta-VLDL) in rabbits fed 2% (w/w) cholesterol for 3 weeks w
as investigated. In vitro studies were also conducted to examine the s
pecificity and the capacity of the uptake in isolated liver parenchyma
l cells. The hepatic uptake of beta-VLDL was 15.8 +/- 6.7% (n = 6) in
the cholesterol-fed rabbits as compared to 26.6 +/- 7.5% (n = 6) of th
e injected dose in control rabbits (P < 0.05). Although this is a frac
tional reduction, it represents a more than 10-fold increase in absolu
te hepatic uptake of lipoproteins in the cholesterol-fed rabbits. In t
hese animals the liver parenchymal, endothelial, and Kupffer cells too
k up 10.2 +/- 2.7%, 3.0 +/- 0.9%, and 1.8 +/- 0.4% of the injected dos
e, respectively, compared to 25.9 +/- 6.1%, 3.6 +/- 1.6%, and 1.5 +/-
0.8% of the injected dose in chow-fed controls. However, taking into a
ccount the high plasma lipoprotein levels in the cholesterol-fed rabbi
ts, the absolute cellular uptake was 10-fold increased in the parenchy
mal liver cells and more than 20-fold increased in the nonparenchymal
cells. In vitro results indicated a 40% down-regulation of the specifi
c receptor for beta-VLDL in the parenchymal cells, and this, together
with an increased competition for binding sites in the hypercholestero
lemic rabbits, probably explains the reduced uptake of beta-VLDL in te
rms of % of injected dose observed in vivo. In vitro data suggested th
at the receptor involved in both hypercholesterolemic and normolipemic
rabbits was the apolipoprotein (apo) B,E receptor. On a per cell basi
s, parenchymal cells from chow-fed control animals took up 2.4 +/- 0.8
% of the injected dose per 10(9) cells; this uptake was reduced to 1.1
+/- 0.5% in hypercholesterolemic animals. No differences in uptake of
beta-VLDL in nonparenchymal liver cells were observed on a per cell b
asis between the two feeding groups, indicating that binding sites inv
olved in this uptake are not down-regulated by cholesterol feeding. On
the contrary, the absolute uptake in the nonparenchymal liver cells i
s greatly increased in hypercholesterolemic rabbits as compared to con
trols. In cholesterol-fed rabbits the three different liver cell types
took up approximately the same amount of beta-VLDL per cell. The live
r non-parenchymal cells, therefore, assume a prominent role in uptake
of beta-VLDL in hypercholesterolemic rabbits, accounting for more than
30% of the total hepatic uptake as compared to 16% in control animals
. Electron microscopic studies showed a significant accumulation of li
pids in all cell types investigated from cholesterol-fed rabbits, whil
e no such lipid accretion could be observed in control rabbits. The in
vivo data show that the nonparenchymal cells, notably the Kupffer cel
ls, play an important role in catabolizing beta-VLDL in hypercholester
olemic rabbits.